Neuroprotection in glaucoma

Cell and Tissue Research

Volumn 353, Issue 2, 2013, Pages 201-203

  Tamm, Ernst R ^a   Grehn, Franz ^b   Pfeiffer, Norbert ^c  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PILOCARPINE;

DISEASE COURSE; ELECTRORETINOGRAPHY; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MICROGLIA; MUELLER CELL; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVE FIBER REGENERATION; NEUROPROTECTION; NONHUMAN; OPTIC NERVE; OPTICAL COHERENCE TOMOGRAPHY; PERIMETRY; PRIORITY JOURNAL; RETINA GANGLION CELL; REVIEW;

CYTOPROTECTION; GLAUCOMA; HUMANS; NEURONS; NEUROPROTECTIVE AGENTS; REGENERATION; RETINAL GANGLION CELLS;

EID: 84880830825     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-013-1672-0     Document Type: Review

References (28)

1. AGIS The Investigators (2000) The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130:429-440
2. Anderson DR, Normal Tension Glaucoma Study Group (2003) Collaborative normal tension glaucoma study. Curr Opin Ophthalmol 14:86-90
3. Bach M, Poloschek CM (2013) Electrophysiology and glaucoma: current status and future challenges. Cell Tissue Res. doi: 10.1007/s00441-013-1598-6
4. Coleman AL (2012) Advances in glaucoma treatment and management: surgery. Invest Ophthalmol Vis Sci 53:2491-2494
5. Collaborative Normal-Tension Glaucoma Study Group (1998a) Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 126:487-497
6. Collaborative Normal-Tension Glaucoma Study Group (1998b) The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 126:498-505
7. Diekmann H, Fischer D (2013) Glaucoma and optic nerve repair. Cell Tissue Res. doi: 10.1007/s00441-013-1596-8
8. Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Kass MA (2002) The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120:714-720, discussion 829-730
9. Karl MO (2013) The potential of stem cell research for the treatment of neuronal damage in glaucoma. Cell Tissue Res. doi: 10.1007/s00441-013-1646-2
10. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Gordon MO (2002) The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120:701-713, discussion 829-730
11. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E (2003) Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 121:48-56
12. Liu Y, Pang IH (2013) Challenges in the development of glaucoma neuroprotection therapy. Cell Tissue Res. doi: 10.1007/s00441-013-1584-z
13. Normando EM, Turner LA, Cordeiro MF (2013) The potential of annexin-labelling for the diagnosis and follow-up of glaucoma. Cell Tissue Res. doi: 10.1007/s00441-013-1554-5
14. Pfeiffer N, Lamparter J, Gericke A, Hoffmann E, Wahl J (2013) Neuroprotection of medical IOP lowering therapy. Cell Tissue Res. doi: 10.1007/s00441-013-1671-1
15. Prasse M, Rauscher FG, Wiedemann P, Reichenbach A, Francke M (2013) Optical properties of retinal tissue and the potential of adaptive optics to visualize retinal ganglion cells in vivo. Cell Tissue Res. doi: 10.1007/s00441-013-1602-1
16. Quigley HA, Cone FE (2013) Development of diagnostic and treatment strategies for glaucoma through understanding and modification of scleral and lamina cribrosa connective tissue. Cell Tissue Res. doi: 10.1007/s00441-013- 1603-0
17. Rauscher FG, Chisholm CE, Edgar DF, Barbur JL (2013) Assessment of novel binocular colour, motion and contrast tests in glaucoma. Cell Tissue Res. doi: 10.1007/s00441-013-1675-x
18. Reardon G, Kotak S, Schwartz GF (2011) Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review. Patient Prefer Adherence 5:441-463
19. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP (2004) Global data on visual impairment in the year 2002. Bull World Health Organ 82:844-851
20. Seitz R, Ohlmann A, Tamm ER (2013) The role of Müller glia and microglia in glaucoma. Cell Tissue Res. doi: 10.1007/s00441-013-1666-y
21. Shiose Y, Kitazawa Y, Tsukahara S, Akamatsu T, Mizokami K, Futa R, Katsushima H, Kosaki H (1991) Epidemiology of glaucoma in Japan-a nationwide glaucoma survey. Jpn J Ophthalmol 35:133-155
22. Sleath B, Blalock S, Covert D, Stone JL, Skinner AC, Muir K, Robin AL (2011) The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology 118:2398-2402
23. Tamm ER, Schmetterer L, Grehn F (2013) Status and perspectives of neuroprotective therapies in glaucoma: The European Glaucoma Society White Paper. Cell Tissue Res. doi: 10.1007/s00441-013-1637-3
24. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY (1995) Global data on blindness. Bull World Health Organ 73:115-121
25. Unsicker K (2013) Neurotrophic molecules in the treatment of neurodegenerative disease with focus on the retina: status and perspectives. Cell Tissue Res. doi: 10.1007/s00441-013-1585-y
26. Weber A (1876) Ueber die Wirkung des Pilocarpium muriaticum. Centralbl Med Wissensch 14:769-772
27. Weber AJ (2013) Autocrine and paracrine interactions and neuroprotection in glaucoma. Cell Tissue Res. doi: 10.1007/s00441-013-1556-3
28. Werkmeister RM, Cherecheanu AP, Garhofer G, Schmidl D, Schmetterer L (2013) Imaging of retinal ganglion cells in glaucoma: pitfalls and challenges. Cell Tissue Res. doi: 10.1007/s00441-013-1600-3